How this Dubai man lost 40 kilos in 5 months (with clean diet and workout)
Image: GulfNews
In just five months, Dubai-based Zubair Chaudhry transformed his life by shedding 40 kilograms, dropping from 135kg to 95kg. His journey began at the end of 2024 when he decided to make significant lifestyle changes.
Chaudhry attributed his weight gain to long work hours, a sedentary lifestyle, and frequent consumption of fast food ordered through delivery apps.
'I was severely overweight. But it wasn't just the weight. I wasn't feeling good about myself, either physically or mentally. My doctor told me: I needed to 'fix' myself," he told Gulf News. 'I live alone in Dubai. As soon as I'd leave my office desk after long working hours, I'd go on these apps and order food.
There were always offers. I'd go for fast food like burgers and pizzas but it was never healthy.'
'I'm not exaggerating but I probably used my kitchen five times in the past two years," he told the media.
Weight loss strategy
Determined to improve his health, Chaudhry eliminated junk food, started cooking at home, and developed a healthy meal plan consisting of salads, raw vegetables, and chicken. He also joined a weight loss challenge, where he lost an additional 34.6kg in just 12 weeks.
He also did not indulge in cheat days except one on his birthday. 'It's not about cravings anymore. I've fallen in love with this lifestyle. I feel amazing physically, emotionally, and mentally.
My self-confidence is growing," he said.
Chaudhry credits his colleagues for their support throughout his journey, stating that their encouragement was instrumental in helping him stay consistent. With only one cheat day on his birthday, he remained disciplined and committed to his new lifestyle.
His next goal is to reach the 80kg range by the end of the year and inspire others to make positive changes in their lives.
What you eat plays a massive role in weight management
When it comes to managing weight, what you eat plays a massive role. You can run all the laps and do all the crunches you want, but if your diet's a mess, it's like trying to bail water out of a sinking boat with a spoon. Good food isn't just about calories; it's about giving your body the fuel it needs to run well, burn fat, and stay healthy in the long run.
T
hink of your body like a car. If you fill it with junk fuel, it won't perform right. But give it high-quality stuff—whole grains, fresh fruits and veggies, lean protein, and healthy fats—and suddenly, things start running a lot smoother. Good food keeps you full longer, helps regulate your blood sugar, and boosts your metabolism. That means fewer cravings, more energy, and a better chance of sticking to your goals.
It's not about starving yourself or cutting out everything you love. It's about balance and making smarter choices. Swapping fried stuff for grilled, soda for water, or chips for a handful of nuts can go a long way. The key is consistency, not perfection.
And let's not forget the emotional part. Eating clean makes you feel good. Less bloating, better mood, clearer skin, your body starts rewarding you for treating it right. So yeah, good food isn't just about losing weight; it's about feeling great while you're at it.
If weight management is the goal, your plate is your most powerful tool. Start small, stay mindful, and remember, it's not a diet, it's a lifestyle shift.
One step to a healthier you—join Times Health+ Yoga and feel the change
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
2 hours ago
- News18
'Was A 15-Minute Procedure': 4-Year-Old Dies After 'Minor' Surgery, Family Alleges Negligence
Last Updated: The family said that the child was admitted to SK Jain Hospital in Delhi for a minor operation A four-year-old boy died after a 'minor" surgery at a hospital in East Delhi's Pandav Nagar on Thursday, with officials confirming that his family has alleged medical negligence. According to the family, Viraj Sharma was admitted to SK Jain Hospital for a minor operation. However, within an hour of being hospitalised, he was declared dead. 'He would have gone to Class 1 next year. They (doctors) told us it was just a 15-minute procedure," Viraj's father, Gaurav Sharma was quoted as saying by The Indian Express. The family added that on May 22, doctors had advised some tests to assess whether Viraj was fit to undergo the procedure. According to the boy's father, the test results came back normal, and the doctors gave the go-ahead for the operation. 'On May 28, the doctor told me to bring my son the next morning. On Thursday, around 8 am, I took my son to the hospital. At 8:40 am, they took him to the Operation Theater and told me that it would be done in 15 minutes," said Gaurav, a graphic designer employed at a Noida-based software company. Gaurav said he waited outside the operation theatre until 9:15 am before receiving any information. 'The doctors said they had given him an injection before the operation, which has caused some reactions. They said he was breathing heavily and that his condition is critical," he recalled. He was then taken into the OT, where, according to him, doctors were using electrical pumps on his son's chest. Shortly after, he was informed that Viraj needed to be transferred to another hospital. 'My son's nose was bleeding, his nails were blue, and his body was cold. He was not moving at all. Still, I took him to Makar Hospital with one last hope," he said. At Makar Hospital, doctors conducted an initial examination and declared the child dead. A police complaint has been lodged at the Pandav Nagar police station, and Sharma has also submitted a written complaint to the DCP East District office. Police confirmed that a post-mortem was conducted on Friday, and the findings are awaited to determine whether medical negligence was involved. 'We have constituted a medical board and the inquiry will start as soon as the post-mortem results are in," said DCP (East) Abhishek Dhania. First Published:
Business Standard
3 hours ago
- Business Standard
World No Tobacco Day 2025: Experts Unite Against Tobacco as a Leading Cause of Cancer and Chronic Diseases
PNN New Delhi [India], May 31: On the occasion of World No Tobacco Day, observed every year on May 31, leading healthcare experts across the country are sounding a clarion call against one of the biggest threats to global health: tobacco. Beyond awareness, experts are demanding urgent action, highlighting tobacco's devastating and far-reaching effects -- from cancer, respiratory, and cardiovascular disease to infertility and second-hand smoke exposure. India currently faces over 37.5 lakh active cancer cases, and tobacco remains the single largest preventable cause. According to a global study published in The Lancet's eClinical Medicine, tobacco-related illnesses cause over 1.3 million cancer-related deaths annually across seven countries, including India. "Smoking is one of the worst carcinogens in the world. Tobacco exposes the entire body, not just the lungs, to cancer-causing agents. It's linked to multiple cancers, including those of the lung, mouth, throat, esophagus, larynx, pancreas, bladder, kidney, stomach, cervix, colon, and even blood cancers like acute myeloid leukemia (AML)," said Dr. Dinesh Singh, Director and Head, Radiation Oncology, Action Cancer Hospital, Delhi. Dr. Singh further warns about second-hand smoke, stating that even non-smokers exposed to it absorb carcinogens and face a significantly elevated cancer risk, especially for lung cancer. "Tobacco smoke promotes chronic inflammation, triggering genetic instability and abnormal cell growth -- a key environment for cancer to develop. Nearly every organ in the body is affected," he explained. Dr. Pritpal Kaur, Pulmonologist, Apollo Spectra Hospital, Karol Bagh, Delhi said, "Tobacco is a toxic cocktail that attacks the respiratory system at every level--from inflaming the airways to permanently damaging lung tissues. COPD, asthma, lung cancer, and bronchitis are just the tip of the iceberg. Tobacco doesn't just suffocate the lungs--it wreaks havoc across the entire body. Every puff poisons not just the smoker, but everyone around them." As India continues to battle its cancer burden, Bengaluru-based SPARSH Group of Hospitals has taken a bold step forward. On May 18, 2025, SPARSH launched its flagship 300-bed multi-speciality hospital on Hennur Road, Bengaluru, introducing its first comprehensive cancer care facility. Backed by world-class infrastructure and an expert team across 50 specialities, the hospital features 75 ICU beds and an integrated oncology program. Dr. Vivek Shetty, Senior Consultant- Head & Neck Oncology, SPARSH Hospital, Hennur Road, Bengaluru said, "Along with lung cancer, oral cancer is also alarmingly common among people who smoke or use tobacco in other forms. There is an urgent need to increase awareness about early detection through proper screening and to encourage timely treatment." "With our new facility at Hennur Road, we now offer best-in-class comprehensive cancer care to combat these life-threatening diseases. Our mission is to bring comprehensive cancer treatment to the doorsteps of people in Karnataka, especially Bengaluru and its neighbouring regions," added Dr. Shetty. The hospital's approach marries precision medicine, compassion, and accessibility, making it a timely answer to Karnataka's growing cancer crisis, where 86,563 new cases are projected annually, with lung and mouth cancers comprising nearly 16% of male cancers. Whether smoked or chewed, tobacco remains the most potent and preventable health hazard. And the consequences go beyond cancer, heart disease, stroke, reproductive disorders, and chronic lung diseases, all bear its imprint. "Tobacco addiction is difficult but not impossible to beat. With modern therapies, counselling, and the right intent, recovery is possible. Every cigarette not smoked is a step toward healing -- not just for the smoker, but for their entire family, said Dr. Arun Kumar Verma, Senior Consultant- Oncology, Chhatrapati Shivaji Subharti Hospital, Meerut. "From lung, oral, and throat cancers to bladder and oesophageal malignancies, tobacco is a common denominator. What's worrying is that even people exposed to secondhand smoke--like family members or co-workers-are--are at risk," warned Dr. Verma, adding, "We must dispel the myth of 'safe usage'. There is no safe level of tobacco exposure." Experts concluded that with early detection, structured cessation programs, and accessible treatment, outcomes can dramatically improve. But quitting tobacco should also be a top priority.
New Indian Express
4 hours ago
- New Indian Express
Sun Pharma's Checkpoint buy: Why it's a strategic fit in the new SPIL focus
CHENNAI: India's largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint Therapeutics for approximately $355 million. This strategic move significantly strengthens Sun Pharma's oncology and dermatology portfolio, aligning with its focus on high-value specialty therapies. Despite the long-term strategic value, the market reaction on Friday surprised many, as Sun Pharma's share price fell by 1.46% at the close of the week's trading. This dip may have been driven by immediate concerns, including regulatory issues at a key manufacturing facility and the company's cautious financial guidance. Investors are closely monitoring developments—particularly the US FDA's observations regarding Sun Pharma's Dahej facility. The company's financial performance in the coming quarters will also be under scrutiny as stakeholders assess the potential impact on its stock trajectory. Strategic Rationale and Synergies of the Checkpoint Deal Drug industry analysts believe the Checkpoint acquisition is a major strategic gain for Sun Pharma, which has historically grown through carefully chosen, high-potential acquisitions. According to analysts at HDFC Securities, the deal aligns with Sun Pharma's capital allocation strategy to strengthen its specialty business. Checkpoint's Unloxcyt—a novel skin cancer drug—will serve as a complementary addition to its oncology portfolio. In the post-Q4 earnings call, Chairman and Managing Director Dilip Shanghvi reiterated the company's commitment to expanding its specialty business. Sun Pharma's specialty and innovative therapeutics division currently focuses on dermatology, ophthalmology, and oncology. Unloxcyt will complement existing products such as Odomzo (sonidegib) and Yonsa (abiraterone acetate)—both approved in the US—Nidlegy (awaiting approval in the EU), and the recently acquired Fibromun (in Phase III trials). Other specialty molecules in development, including Ilumya (for psoriatic arthritis), GL0034 (obesity), MM-II (osteoarthritis), SCD-044 (atopic dermatitis/psoriasis), and Fibromun (for soft tissue sarcoma/glioblastoma), offer long-term growth potential. According to analysts, the Checkpoint acquisition is strategically significant for four key reasons:
